# Missouri

Type: government

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/missouri-government
Canonical HTML page: https://gethealthbrief.com/entity/missouri-government

## Timeline

- **2026-03-21**: Contact Tracing Expansion — Epidemiologists begin interviewing patients to map potential community exposure sites.
- **2026-03-20**: Initial Diagnosis — Two Missouri residents are confirmed positive for mpox by state laboratories.
- **2026-03-20**: Public Health Alert — Missouri DHSS issues a formal notice to clinicians to increase screening and reporting.
- **2026-03-13**: DOJ Missouri Filing — DOJ quietly asks the Missouri court to pause proceedings pending FDA review.
- **2026-03-11**: Legislative Action — Sen. Josh Hawley introduces a Senate bill to outright ban the abortion pill.
- **2026-01-20**: Louisiana Precedent — DOJ unsuccessfully asks Louisiana to pause its separate anti-abortion lawsuit.
- **2025-11-15**: Amended Complaint — AG Catherine Hanaway adds claims that mail-order drugs are dangerous without in-person visits.
- **2025-10-01**: Lawsuit Filed — Missouri, Kansas, and Idaho file suit against the FDA over mifepristone regulations.

## Recent coverage (3 stories)

### Missouri Reports First Mpox Cases: Public Health Infrastructure on Alert
2026-03-21 01:20:02 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

The Missouri Department of Health and Senior Services has confirmed the state's first two cases of mpox, triggering immediate containment protocols. Health officials are now prioritizing contact tracing and the deployment of diagnostic resources to prevent community transmission.
Full story: https://gethealthbrief.com/story/missouri-first-mpox-cases-2026

### DOJ Requests Pause in Missouri Mifepristone Lawsuit Citing Internal FDA Review
2026-03-13 00:34:35 · Sentiment: Bearish · Impact: 8/10 · Sources: 2

The U.S. Department of Justice has requested a federal court in Missouri to pause or dismiss a lawsuit targeting the FDA's approval of mifepristone, citing an ongoing internal agency review. This move reflects a strategic effort by the administration to manage high-stakes litigation over medication abortion and telehealth access ahead of the 2026 midterms.
Full story: https://gethealthbrief.com/story/doj-missouri-mifepristone-lawsuit-pause

### Missouri and Kansas Health Insurance Costs Hit Critical 10% Income Threshold
2026-02-25 03:49:33 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Families in Missouri and Kansas are now spending nearly 10% of their median household income on employer-sponsored health insurance premiums. This surge reflects a broader national trend of rising healthcare costs outpacing wage growth, potentially triggering affordability challenges under federal guidelines.
Full story: https://gethealthbrief.com/story/missouri-kansas-health-insurance-affordability-crisis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.